IBDEI0W6 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15634,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,15635,0)
 ;;=V10.47^^81^946^75
 ;;^UTILITY(U,$J,358.3,15635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15635,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,15635,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,15635,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,15636,0)
 ;;=V10.83^^81^946^73
 ;;^UTILITY(U,$J,358.3,15636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15636,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,15636,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,15636,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,15637,0)
 ;;=285.22^^81^946^9
 ;;^UTILITY(U,$J,358.3,15637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15637,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,15637,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,15637,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,15638,0)
 ;;=285.21^^81^946^10
 ;;^UTILITY(U,$J,358.3,15638,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15638,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,15638,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,15638,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,15639,0)
 ;;=285.29^^81^946^11
 ;;^UTILITY(U,$J,358.3,15639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15639,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,15639,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,15639,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,15640,0)
 ;;=284.9^^81^946^12
 ;;^UTILITY(U,$J,358.3,15640,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15640,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,15640,1,5,0)
 ;;=5^Aplastic Anemia NOS
 ;;^UTILITY(U,$J,358.3,15640,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,15641,0)
 ;;=282.61^^81^946^78
 ;;^UTILITY(U,$J,358.3,15641,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15641,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,15641,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,15641,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,15642,0)
 ;;=282.7^^81^946^77
 ;;^UTILITY(U,$J,358.3,15642,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15642,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,15642,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,15642,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,15643,0)
 ;;=283.9^^81^946^79
 ;;^UTILITY(U,$J,358.3,15643,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15643,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,15643,1,5,0)
 ;;=5^Hemolytic Anemia,Acquired
 ;;^UTILITY(U,$J,358.3,15643,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,15644,0)
 ;;=283.0^^81^946^80
 ;;^UTILITY(U,$J,358.3,15644,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15644,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,15644,1,5,0)
 ;;=5^Hemolytic Anemia,Autoimmune
 ;;^UTILITY(U,$J,358.3,15644,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,15645,0)
 ;;=282.9^^81^946^81
 ;;^UTILITY(U,$J,358.3,15645,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15645,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,15645,1,5,0)
 ;;=5^Hemolytic Anemia,Hereditary
 ;;^UTILITY(U,$J,358.3,15645,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,15646,0)
 ;;=283.19^^81^946^82
 ;;^UTILITY(U,$J,358.3,15646,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15646,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,15646,1,5,0)
 ;;=5^Hemolytic Anemia,Microang
 ;;^UTILITY(U,$J,358.3,15646,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,15647,0)
 ;;=280.9^^81^946^86
 ;;^UTILITY(U,$J,358.3,15647,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15647,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,15647,1,5,0)
 ;;=5^Iron Defic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,15647,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,15648,0)
 ;;=285.1^^81^946^84
 ;;^UTILITY(U,$J,358.3,15648,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15648,1,4,0)
 ;;=4^285.1
 ;;
 ;;$END ROU IBDEI0W6
